Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Outcome After Neuro-Interventional Treatment of Intracranial Aneurysm (As a First Treatment Modality) Publisher Pubmed



Ghanaati H1 ; Rahmatian A2, 3 ; Amirinikpour MR3 ; Altafi D3 ; Taheri M3, 4 ; Siroos SB3 ; Shakiba M1 ; Elahi R1 ; Avanaki MA1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Emam-Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Neurology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran
  3. 3. Iranian Center of Neurological Research, Department of Neurovascular Intervention, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Iran University of Medical Sciences, Tehran, Iran

Source: Prague Medical Report Published:2024


Abstract

Endovascular treatment is widely applied as the first-line treatment for intracranial aneurysms and includes simple coiling (SC), stent-assisted coiling (SAC), flow diversion stent, and flow disruption stent. The present study is a retrospective cohort study performed in Imam Khomeini Hospital, Department of Neurovascular Intervention, between March 2016 and March 2021. A total number of 229 patients with intracranial aneurysms who underwent therapeutic intravascular interventions were enrolled, of which 89 were treated with SC, 111 with SAC, 25 with flow diversion stent, and 4 with flow disruption stent. The mean age of the subjects was 51.8±12.6 years, and 51.1% were male. Modified Raymond-Roy classification (MRRC) was used to define the occlusion outcome. The success rate, considered as Class I and Class II of MRRC at treatment time was 89% (94.4% in SC, and 84.7% in SAC), which was increased to 90.9% (94% in SC, 93% in SAC, 69.6% in flow diversion stenting, 100% in flow disruption) at 6-month follow-up, and 84.6% (80.8% in SC, 87.8% in SAC, 78.3% in flow diversion stenting, and 100% in flow disruption) at 12-month follow-up. The mean © 2024 Karolinum - Nakladatelstvi Univerzity Karlovy. All rights reserved.